Trial intelligence / Profile preview

Perioperative iloprost in severe pulmonary hypertension during non-cardiac surgery

ChiCTR-ONC-12002826Phase 4Completed

Sponsor
Beijing Shijitan Hospital
Start
Jan 2008
Modality
Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
Countries
1
01

Overview

Phase 4, open-label, single-arm trial of iloprost in pulmonary arterial hypertension (PAH) and pulmonary hypertension (PH), sponsored by Beijing Shijitan Hospital. Primary endpoint: Pulmonary hemodynamic indices. Started Jan 2008; status: completed.

02

Drugs

iloprost
03

Conditions

pulmonary arterial hypertension (PAH)pulmonary hypertension (PH)

Beyond the preview

Go deeper on ChiCTR-ONC-12002826.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ChiCTR-ONC-12002826.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call